Progyny (PGNY)

• Market cap: $1.28B
• 1 day: 0.81%
• 5 days: -2.41%
• 1 month: -5.00%
• 3 months: -36.68%
• 6 months: -45.34%
• Year to date: -59.69%
• 1 year: -57.57%
• 5 years: -46.16%
• 10 years: -5.90%
• Sector: Healthcare
• Industry: Miscellaneous Health & Allied Services

About: Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Employees: 566

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

43% more call options, than puts

Call options by funds: $3.47M | Put options by funds: $2.43M

0% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 96

1.3% less ownership

Funds ownership: 95.57% [Q2] → 94.27% (-1.3%) [Q3]

13% less funds holding

Funds holding: 322 [Q2] → 280 (-42) [Q3]

41% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 102

47% less capital invested

Capital invested by funds: $2.6B [Q2] → $1.38B (-$1.22B) [Q3]

57% less funds holding in top 10

Funds holding in top 10: 7 [Q2] → 3 (-4) [Q3]

Research analyst outlook

12 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $17 13% upside
• Avg. target: $21 40% upside
• High target: $26 73% upside

12 analyst ratings

• positive: 7 58%
• neutral: 5 42%
• negative: 0 0%

JP Morgan Anne Samuel 36% 1-year accuracy 4 / 11 met price target	13% upside $17	Neutral Downgraded	2 Dec 2024
Barclays Sarah James 39% 1-year accuracy 48 / 122 met price target	13% upside $17	Overweight Maintained	14 Nov 2024
B of A Securities Michael Cherny 58% 1-year accuracy 15 / 26 met price target	40% upside $21	Buy Maintained	13 Nov 2024
Canaccord Genuity Richard Close 64% 1-year accuracy 7 / 11 met price target	13% upside $17	Hold Maintained	13 Nov 2024
Truist Securities Jailendra Singh 11% 1-year accuracy 2 / 18 met price target	27% upside $19	Hold Downgraded	13 Nov 2024